Table 3 presents the pathological parameters of all patients with endometrial cancers, bearing two identifiable sizes of CAMLs—tiny and giant. In turn, Table 4 tabulates the CAMLs present in the blood of patients, as categorized by stage, grade, lymph node positivity, LVI, and myometrial invasion of the tumors. CAML+ve patients predominantly present endometrioid adenocarcinoma histology (Table 5). Here, CAMLG is linked to endometrioid adenocarcinoma.